36942-full
cpt_c_pike
Sex: M
Data Quality: 1 star
ALS: 6 yrs
Bulbar: none
Arms: moderate
Chest: none
Legs: mild
cpt_c_pike
Male, 39 years
montreal, QC
Primary Condition
ALS and 1 more
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

cpt_c_pike's Intravenous Immuno Globulin IVIg is for:

  • ALS

cpt_c_pike has not reported any side effects for Intravenous Immuno Globulin IVIg.

cpt_c_pike's Intravenous Immuno Globulin IVIg History (Ongoing)
40 g Weekly Aug 29, 2011 - Mar 30, 2012
80 mg Weekly Apr 27, 2012 - Last Update
Stopped Course of treatment ended and Other Mar 30, 2012
Evaluations
Date Dosage ALS (Amyotrophic Lateral Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Mar 30, 2012 40 g Weekly ? NoneNoneNoneNone AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Date
Mar 30, 2012
Advice & Tips
didnt catch any colds over course stop is to evaluate effect severe side effects 1st week only

About Intravenous Immuno Globulin IVIg (Prescription Drug)

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immunodeficiency disorders, B-cell chronic lymphocytic leukemia, inflammatory demyelinating disorders. Off label uses include Guillain-Barré, Multiple Sclerosis, and myasthenia gravis.

Learn more about Intravenous Immuno Globulin IVIg in our Intravenous Immuno Globulin IVIg Community Report.